Investor Profile: A91 Partners — the $665M growth-stage bet on India

A91 Partners is one of India's defining growth-stage investors: a Mumbai-based firm founded in 2018 by Abhay Pandey, V.T. Bharadwaj and Gautam Mago, three former directors of Sequoia Capital India who left to build a world-class, India-first investment house. In April 2025 the firm closed A91 Fund III at $665 million, its largest fund yet, taking total assets under management past $1.5 billion. The firm's stated creed — patient capital accelerating value creation in Indian businesses — is plastered across its own site: "Our pursuit is to be exceptional investment partners for founders embarking on a growth journey."

Thesis and focus areas

A91 backs small to mid-sized companies at the growth stage, typically Series B and C, across consumer goods, financial services, healthcare and technology — new-age brands and tech-enabled businesses built for India. The firm describes itself as a small team with shared beliefs: velocity over raw speed, commitments over bets, and the whole firm — not just one partner — behind every investment. It operates from Mumbai (Worli) and GIFT City, Gandhinagar.

Fund size and cheque size

A91 has scaled its capital base relentlessly: the $351 million debut fund in July 2019, a $550 million second fund in 2021, and A91 Fund III closed at $665 million in April 2025 against a $675 million target. The International Finance Corporation, the World Bank Group's private-sector arm and a repeat LP across all three funds, committed $35 million to Fund III with a $30 million co-investment envelope. Cheques land between $10 million and $50 million per deal, with the firm typically writing around $10–15 million in a round; Fund III was expected to back roughly 15 companies.

Notable portfolio

A91's portfolio reads like a who's who of Indian consumer and fintech growth stories: Go Digit General Insurance (which went public in 2024), HealthKart, Atomberg, Blue Tokai Coffee Roasters, Sugar Cosmetics, Paper Boat, The House of Rare (Rare Rabbit), Akshayakalpa Organic, EatClub, Giva, Plum, Inshorts, Freshworks, Exotel, Aye Finance, Ummeed Housing Finance, FinBox and Happilo. Per Tracxn, the firm spans some 34 companies across India, the US and Singapore.

Partners

The firm was founded by Abhay Pandey, V.T. Bharadwaj and Gautam Mago, all formerly with Sequoia Capital India. A91 deliberately keeps a compact team and stresses collective decision-making — its site states that it brings the entire firm to every investment, not just an individual partner. General contact: [email protected], (022) 6871-0400.

Programs, credits and perks

Unlike some peers, A91 runs no public accelerator, seed programme or founder credits-and-perks stack. Its post-investment edge is hands-on, patient growth partnership and a concentrated portfolio — 15 to 17 companies per fund — which means each founder gets meaningful partner time rather than a perks catalogue.

How founders can approach them

A91 is a growth-stage firm: come to them with product-market fit, revenue traction and a category-leadership story, not a seed deck. Warm introductions via founders in their portfolio — Digit, HealthKart, Atomberg, Blue Tokai — carry the most weight. Expect a deliberate, partnership-oriented diligence process from a firm that positions itself as patient capital.